Piper Sandler Upgrades Organon to Neutral, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 80.3%

Neg 0% Neu 0% Pos 80.3%

Piper Sandler analyst David Amsellem upgrades Organon (NYSE:OGN) from Underweight to Neutral and raises the price target from $5 to $14.